Interpreting serological studies on severe acute respiratory syndrome: defining the reference
Interpreting serological studies on severe acute respiratory syndrome: defining the reference
摘要
Severe acute respiratory syndrome (SARS) was first identified in November 2002 in China and spread internationally causing more than 910 deaths before being contained in 2003. A novel coronavirus, named SARS coronavirus (SARS CoV) has been identified as the etiologic agent of SARS.~1
Severe acute respiratory syndrome (SARS) was first identified in November 2002 in China and spread internationally causing more than 910 deaths before being contained in 2003. A novel coronavirus, named SARS coronavirus (SARS CoV) has been identified as the etiologic agent of SARS.~1
参考文献10
-
1DrostenC,PreiserW,GuntherS,etal.Severeacute respiratorysyndrome:identificationoftheetiologicalagent[].Trends in Molecular Medicine.2003
-
2SunY,YaoW,WangX,etal.Clinicaldiagnosticapproach tosevereacuterespiratorysyndrome:aninstitution’s experience[].Chinese Medical Journal.2003
-
3CentersforDiseaseControlandPrevention(CDC).Revised U.S.surveillancecasedefinitionforsevereacuterespiratory syndrome(SARS)andupdateonSARScases-UnitedStates andworldwide,December2003[].MMWRMorbMortalWkly Rep.2003
-
4TanYJ,GohPY,FieldingBC,etal.Profilesofantibody responsesagainstsevereacuterespiratorysyndrome coronavirusrecombinantproteinsandtheirpotentialuseas diagnosticmarkers[].ClinDiagnLabImmunol.2004
-
5LeongHN,ChanKP,KhanAS,etal.Virus specificRNA andantibodyfromconvalescent phaseSARSpatients dischargedfromhospital[].EmergInfectDis.2004
-
6WooPC,LauSK,WongBH,etal.Longitudinalprofileof immunoglobulinG(IgG),IgM,andIgAantibodiesagainst thesevereacuterespiratorysyndrome(SARS)coronavirus nucleocapsidproteininpatientswithpneumoniaduetothe SARScoronavirus[].ClinDiagnLabImmunol.2004
-
7LiuX,ShiY,LiP,etal.Profileofantibodiestothe nucleocapsidproteinofthesevereacuterespiratorysyndrome (SARS) associatedcoronavirusinprobableSARSpatients[].ClinDiagnLabImmunol.2004
-
8TsoEY,TsangOT,LamB,etal.Naturalcourseofsevere acuterespiratorysyndrome associatedcoronavirus immunoglobulinafterinfection[].The Journal of Infectious Diseases.2004
-
9BuchholzUJ,BukreyevA,YangL,etal.Contributionsof thestructuralproteinsofsevereacuterespiratorysyndrome coronavirustoprotectiveimmunity[].Proceedings of the National Academy of Sciences of the United States of America.2004
-
10MOHY,XuJ,RENXL,etal.Evaluationofthedynamic changesofserumantibodyresponsesagainstsevereacute respiratorysyndrome coronavirusbyindirect immunofluorescentassayandenzyme linkedimmunosorbent assay[].Chinese Medical Journal.2005
-
1苏翔.SARS的流行病学特征及临床研究现况[J].右江医学,2003,31(4):379-381.
-
2ZHANGChuan-hai,WANGYi-fei,LIUXin-jian,LUJia-hai,QIANChui-wen,WANZhuo-yue,YANXin-ge,ZHENGHuan-ying,ZHANGMei-ying,XIONGSheng,LIJiu-xiang,QIShu-yuan.Antiviral activity of cepharanthine against severe acute respiratory syndrome coronavirus in vitro[J].Chinese Medical Journal,2005(6):493-496. 被引量：11
-
3口服降糖药治疗的2型糖尿病孕妇的血糖控制和妊娠结局[J].中华围产医学杂志,2017,20(2):97-97.
-
4谭春梅.SARS流行病学研究现况[J].广西预防医学,2003,9(3):182-185. 被引量：8
-
5Laurie Goodman.EBV conference establishes goals for defining disease-related EBV subtypes for vaccine development[J].癌症,2009,28(12):1233-1235.
-
6周密,李凡.SARS冠状病毒S蛋白研究进展[J].中国实验诊断学,2003,7(6):549-551.
-
7罗湘蜀,梁莉.SARS——认识一种新的传染病[J].预防医学情报杂志,2003,19(3):279-286. 被引量：1
-
8王艳斌,谢雯.《丙型肝炎防治指南(2015年更新版)》解读[J].中华实验和临床感染病杂志（电子版）,2015,9(6):1-4. 被引量：4
-
9张翼飞,洪洁,宁光.二甲双胍对比格列吡嗪对2型糖尿病合并冠心病患者心血管事件的影响[J].中华内科杂志,2013,52(10):861-861. 被引量：9
-
10MIN LIU,WAN-NIAN LIANG,QI CHEN,XUE-QIN XIE,JIANG WU,XIONG HE,ZE-JISN LIU.Risk Factors for SARS-Related Deaths in 2003, Beijing[J].Biomedical and Environmental Sciences,2006,19(5):336-339.
